Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Cancer
Interventions: OTHER: non-drug intervention educational programme
Sponsor: GlaxoSmithKline